NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

More News From Enter Hollywood

Zhang Yimou's 'One Second' dropped from Berlin film festival

Feb 20, 2019

BEIJING — The latest film from famed Chinese director Zhang Yimou has been dropped from the Berlin film festival for what the festival described as technical reasons. A notice on the official Weibo microblogging service account for the movie "One Second" apologized but gave no details other than to say it was not possible to show the film at Berlin. The festival said the film was pulled because of "technical difficulties encountered during post-production." It said the movie would be replaced at its scheduled Friday and Saturday showings with Zhang's action epic "Hero," which premiered in 2002 at the Great...

Pat Cummins voted Australia's cricketer of the year

Feb 20, 2019

MELBOURNE, Australia — Fast bowler Pat Cummins won Australian cricket's highest individual honor on Monday for his performances during a year when the national team's results were overshadowed by bans for Steve Smith and David Warner following a ball-tampering scandal. Cummins won the Allan Border medal for Australia's leading men's cricketer with 156 votes, six ahead of off-spinner Nathan Lyon, who was voted test cricket player of the year. Alyssa Healy won the Belinda Clark award for the leading Australian women's cricketer of the year. Cummins took 44 wickets at an average of 25.61 across all formats during the 12-month...

South Korean women begin to resist intense beauty pressure

Feb 20, 2019

SEOUL, South Korea — As she pursued her dream of becoming a fashion model, veering for years between extreme dieting and overeating, Park I Seul realized she had a problem: She was not tall and skinny, like typical runway models, nor was she big enough to be a plus-size model. She also realized that the only way to meet South Korea's lofty beauty standards was for her to continuously deny who she truly is. So Park, 25, began calling herself a "natural size model" — a nearly unheard of term in South Korea — which she defines as someone with...

Australia into Davis Cup finals in Madrid

Feb 20, 2019

ADELAIDE, Australia — Australia won its Davis Cup qualifier against Bosnia and Herzegovina 4-0 to secure a spot in this year's 18-team final in Madrid. The Australian doubles pair of John Peers and Jordan Thompson defeated Mirza Basic and Tomislav Brkic 7-5, 6-1 on Saturday on hard courts at Memorial Drive to give the home side an unbeatable 3-0 lead. Alexei Popyrin, in his Davis Cup debut, followed with a 6-1 7-6 (2) victory over Nerman Fatic. The fifth match was not played. On Friday's opening day, John Millman and Alex de Minaur gave Australia its 2-0 lead. Millman defeated...

Now No. 1, Osaka wins majors to strains of Jay Rock's 'Win'

Feb 20, 2019

MELBOURNE, Australia — Like the 21-year-old she is, Naomi Osaka stepped into Rod Laver Arena for the Australian Open final with a cellphone in her right hand and music in both ears. The headphones she wore carried the swirling brass, bouncing beat and boastful lyrics of Jay Rock's "Win," the same pre-match song Osaka listened to throughout the tournament — and at last year's U.S. Open, too. "You might wanna keep score," the rapper says. "I win, win, win, win." Right now, that's how Osaka is living at tennis' most important events. Her championship at Melbourne Park, via a 7-6...

Sign up now!